Brinker Capital Investments, LLC Moderna, Inc. Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 8,529 shares of MRNA stock, worth $569,993. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,529
Previous 6,573
29.76%
Holding current value
$569,993
Previous $777,000
97.04%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
1,114Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.9 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.64 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.71 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$483 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $26.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...